company background image
RMTI

Rockwell Medical NasdaqCM:RMTI Stock Report

Last Price

US$2.06

Market Cap

US$22.0m

7D

31.2%

1Y

-69.3%

Updated

16 Aug, 2022

Data

Company Financials +
RMTI fundamental analysis
Snowflake Score
Valuation5/6
Future Growth1/6
Past Performance0/6
Financial Health4/6
Dividends0/6

RMTI Stock Overview

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally.

Rockwell Medical, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Rockwell Medical
Historical stock prices
Current Share PriceUS$2.06
52 Week HighUS$7.70
52 Week LowUS$1.17
Beta1.21
1 Month Change68.85%
3 Month Change5.10%
1 Year Change-69.34%
3 Year Change-92.45%
5 Year Change-97.18%
Change since IPO-96.35%

Recent News & Updates

Aug 12

Rockwell Medical Q2 Earnings Preview

Rockwell Medical (NASDAQ:RMTI) is scheduled to announce Q2 earnings results on Monday, August 15th, before market open. The consensus EPS Estimate is -$0.81 (-800.0% Y/Y) and the consensus Revenue Estimate is $16.8M (+11.0% Y/Y). Over the last 3 months, EPS estimates have seen 0 upward revision and 0 downward. Revenue estimates have seen 0 upward revision and 0 downward.

Shareholder Returns

RMTIUS Medical EquipmentUS Market
7D31.2%3.6%4.5%
1Y-69.3%-20.7%-8.9%

Return vs Industry: RMTI underperformed the US Medical Equipment industry which returned -19.6% over the past year.

Return vs Market: RMTI underperformed the US Market which returned -9.6% over the past year.

Price Volatility

Is RMTI's price volatile compared to industry and market?
RMTI volatility
RMTI Average Weekly Movement14.4%
Medical Equipment Industry Average Movement9.4%
Market Average Movement7.6%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: RMTI is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 14% a week.

Volatility Over Time: RMTI's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
1996300Mark Strobeckhttps://www.rockwellmed.com

Rockwell Medical, Inc., together with its subsidiaries, operates as a biopharmaceutical company that targets end-stage renal disease and chronic kidney disease with therapies and products for the treatment of iron deficiency and hemodialysis in the United States and internationally. The company offers Triferic Dialysate and Triferic AVNU, an iron therapy that replaces iron and maintains hemoglobin in dialysis patients without increasing iron stores. It also manufactures, sells, delivers, and distributes hemodialysis concentrates, such as CitraPure citric acid concentrate, Dri-Sate dry acid concentrate, RenalPure liquid acid concentrate, dry acid concentrate mixer, and RenalPure and SteriLyte powder bicarbonate concentrate; and ancillary products, including blood tubing, fistula needles, dialyzers, drugs, specialized component kits, dressings, cleaning agents, filtration salts, and other supplies used by hemodialysis providers.

Rockwell Medical, Inc. Fundamentals Summary

How do Rockwell Medical's earnings and revenue compare to its market cap?
RMTI fundamental statistics
Market CapUS$21.99m
Earnings (TTM)-US$28.65m
Revenue (TTM)US$66.13m

0.3x

P/S Ratio

-0.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
RMTI income statement (TTM)
RevenueUS$66.13m
Cost of RevenueUS$67.73m
Gross Profit-US$1.60m
Other ExpensesUS$27.05m
Earnings-US$28.65m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-2.68
Gross Margin-2.42%
Net Profit Margin-43.33%
Debt/Equity Ratio84.4%

How did RMTI perform over the long term?

See historical performance and comparison